ASENAPINE MALEATE, 95%, 50mg

4,7-Dibromobenzo[c][1,2,5]oxadiazole, 95.0%, 1g

Compresses froides/chaudes, 280 x 150 mm, 5 pièces

(S)-2-(5-Amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanamido)acetic acid, 95.0%, 250mg

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)1g

tert-Butyl 2,7-diazaspiro[4.4]nonane-2-carboxylate, 96.0%, 25g

Éther diéthylique, ROTIDRY®, plus min. 99,5 % (max. 50 ppm H2O), 1 L, emballage en verre

Fmoc-(S)-3-Amino-4-(3-thienyl)-butyric acid, 98%, 2g

3,4-Dibromo-6-fluoro-2-methoxyphenol, 98%, 1g

3-amino-4-(tert-butyl)benzoic acid hydrochloride, 95.0%, 250mg

5-METHYLAZEPAN-4-ONE HCL, 95.0%, 100mg

3-(2-Ethoxyphenyl)-1H-pyrazole-5-carboxylic acid, 95.0%, 2.5g

2-methyl-1H-benzimidazol-4-ol, 95.0%, 1g